The FDA's latest effort to end the use of antibiotics as growth promoters in animals is getting mixed reviews from activists.
April 11, 2012 The U.S. Food and Drug Administration says it will collaborate with the livestock industry to reduce the use of antibiotics in animal feed. But activists say a voluntary approach won't go nearly far enough to protect human health.
<iframe src="http://www.npr.org/player/embed/150432234/150446092" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
April 4, 2012 U.S. medical practices bought counterfeit medicine labeled as Altuzan from a foreign supplier, the FDA says. Altuzan, which is the Turkish brand name for the blockbuster drug Avastin, is approved for use in Turkey but not in this country.
March 9, 2012 Some skin-lightening cosmetics contain dangerous amounts of mercury, the FDA warned consumers. Though illegal to sell in the U.S., the foreign-made products are popular in communities where fair skin is considered a mark of beauty.
A woman holds an AeroShot inhalable caffeine device in Boston.
March 7, 2012 When the inhalable caffeine product, known as AeroShot, hit college campus stores back in January, it caused a buzz, not all of it euphoric. Now the U.S. Food and Drug Administration has warned the company that makes it about the labeling and safety of its product.
March 7, 2012 Scientists at the Food and Drug Administration are feeling more optimistic about the future of their agency than they were back in 2006, according to a survey just out from the Union of Concerned Scientists. But they still report concerns about outside pressures on the agency's decisions and policies.
Raw milk lovers trust the stuff that comes straight from the cow more than they trust the FDA.
March 5, 2012 Public health officials will have a hard time convincing raw milk advocates that the product is dangerous, according to a new study.
February 29, 2012 U.S. District Court Judge Richard Leon in Washington ruled that a requirement for cigarette makers to put large, gruesome labels on their products violates free speech rights. Foes of the tobacco industry urged the Justice Department to appeal.
Lipitor, and other cholesterol-fighting drugs like it, will carry new instructions about risks.
February 28, 2012 Statins may also increase the risk slightly for high blood sugar and for developing Type 2 diabetes. People have also complained about memory loss and fuzzy thinking while taking the cholesterol-fighting drugs. Now the Food and Drug Administration wants that information added to the drugs' instructions.
February 22, 2012 In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart rates, the panel determined.
<iframe src="http://www.npr.org/player/embed/147253725/147267420" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Clover sprouts look to be the source of the latest e. coli outbreak.
February 17, 2012 With yet another outbreak of sprout-related illness, sprouts growers they need the FDA to provide new rules so they can test new techniques for reducing risk.
The FDA hasn't approved a new weight-loss drug since 1999. In the meantime, Americans' waistlines have continued to grow.
M. Spencer Green/AP
February 17, 2012 The Food and Drug Administration will take a second look at a weight-loss drug it rejected in 2010. The decision to review Qnexa comes as the agency is rethinking how it judges weight-loss drugs. Though obesity is at epidemic levels, the FDA hasn't approved any new weight-loss medicines since 1999.
<iframe src="http://www.npr.org/player/embed/146988891/147028197" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Many hospitals are perilously close to running out of a form of methotrexate that's necessary to inject in high doses to treat certain forms of cancer.
February 16, 2012 Many hospitals around the nation are perilously close to running out of a form of the old standby cancer drug methotrexate. The reason: a principal supplier of injectable methotrexate shut down in November after it flunked an FDA inspection.
<iframe src="http://www.npr.org/player/embed/146960417/146969196" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
February 15, 2012 Counterfeit versions of diet drugs, Lipitor and a flu medication called Tamiflu have been found in this country before. But so far fake cancer medicines have been rare.
February 15, 2012 A consortium of consumer and environmental groups says there's too much lead in lipstick. The Food and Drug Administration says there's nothing to worry about.
When it comes to taking up residence in your intestines, Clostridium difficile, like these, may get some help from common heartburn drugs.
February 8, 2012 Nexium, Prilosec and Prevacid are among the popular medicines — called proton pump inhibitors — that may raise the risk for chronic diarrhea caused by Clostridium difficile. That's a bacterium that you'd rather not have colonizing your intestines.
NPR thanks our sponsors
Become an NPR sponsor